NASDAQ:AXSM | Operating Income | Axsome Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2014-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$49.65M
2026-03-31-$63.36M
2025-12-31-$26.96M
2025-09-30-$46.11M
2025-06-30-$36.71M
2025-03-31-$56.98M
2024-12-31-$72.62M
2024-09-30-$62.62M
2024-06-30-$78.05M
2024-03-31-$67.28M
2023-12-31-$98.27M
2023-09-30-$62.12M
2023-06-30-$65.06M
2023-03-31-$6.37M
2022-12-31-$59.92M
2022-09-30-$42.41M
2022-06-30-$39.18M
2022-03-31-$38.29M
2021-12-31-$32.61M
2021-09-30-$33.41M
2021-06-30-$30.85M
2021-03-31-$27.84M
2020-12-31-$27.74M
2020-09-30-$21.13M
2020-06-30-$17.78M
2020-03-31-$32.49M
2019-12-31-$24.43M
2019-09-30-$18.95M
2019-06-30-$13.45M
2019-03-31-$10.42M
2018-12-31-$9.45M
2018-09-30-$8.24M
2018-06-30-$7.99M
2018-03-31-$7.16M
2017-12-31-$6.44M
2017-09-30-$6.3M
2017-06-30-$6.75M
2017-03-31-$7.67M
2016-12-31-$7.63M
2016-09-30-$7.21M
2016-06-30-$6.83M
2016-03-31-$5.88M
2015-12-31-$3.15M
2015-09-30-$2.02M
2015-06-30-$2.08M
2015-03-31-$1.93M

Annual Operating Income

DateOperating Income
2025-12-31-$166.76M
2024-12-31-$280.56M
2023-12-31-$231.83M
2022-12-31-$179.8M
2021-12-31-$124.71M
2020-12-31-$99.14M
2019-12-31-$67.25M
2018-12-31-$32.85M
2017-12-31-$27.16M
2016-12-31-$27.54M
2015-12-31-$9.2M
2014-12-31-$5.67M